Taro Amagata
- Biotechnology top 1%
- Marine Sponges and Natural Products 20
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis 14
- Toxicology top 5%
- Organic Chemistry top 10%
- Synthetic Organic Chemistry Methods 11
- Asymmetric Synthesis and Catalysis 1
- Aquatic Science top 10%
-
- Synthesis and Biological Activity 4
-
- Traditional and Medicinal Uses of Annonaceae 2
-
- Phytochemical Studies and Bioactivities 2
-
- Phytochemistry and Bioactive Compounds 1
- Co-authors
- Phillip CrewsKatsuhiko MinouraAtsushi NumataKaren TenneyFrederick A. ValerioteTadayoshi ItoEmil B. LobkovskyJon Clardy
- Cited by
- BiotechnologyPharmacologyToxicology
- Journals
- Chemical Communications (1 paper)Journal of Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (2 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Taro Amagata
22 papers receiving 807 citations
Peers
Comparison fields: 5 of 68
- Biotechnology 410
- Pharmacology 469
- Toxicology 46
- Organic Chemistry 321
- Aquatic Science 49
Countries citing papers authored by Taro Amagata
This map shows the geographic impact of Taro Amagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Amagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Amagata more than expected).
Fields of papers citing papers by Taro Amagata
This network shows the impact of papers produced by Taro Amagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Amagata. The network helps show where Taro Amagata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Taro Amagata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Discovery and development of anticancer agents from marine sponges: perspectives based on a chemistry-experimental therapeutics collaborative program. | 2012 | 31 |
| 2 | 2011 | 31 | |
| 3 | 2010 | 22 | |
| 4 | 2009 | 15 | |
| 5 | 2008 | 13 | |
| 6 | 2008 | 32 | |
| 7 | 2008 | 77 | |
| 8 | 2007 | 22 | |
| 9 | 2004 | 51 | |
| 10 | 2004 | 19 | |
| 11 | 2004 | 3 | |
| 12 | 2003 | 67 | |
| 13 | 2003 | 88 | |
| 14 | 2000 | 19 | |
| 15 | 1999 | 68 | |
| 16 | 1998 | 70 | |
| 17 | 1998 | 30 | |
| 18 | 1998 | 39 | |
| 19 | 1998 | 37 | |
| 20 | 1997 | 31 |
About Taro Amagata
Taro Amagata is a scholar working on Biotechnology, Pharmacology and Organic Chemistry, having authored 22 papers that have together received 843 indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (20 papers), Microbial Natural Products and Biosynthesis (14 papers), Synthetic Organic Chemistry Methods (11 papers), Synthesis and Biological Activity (4 papers), Traditional and Medicinal Uses of Annonaceae (2 papers), Phytochemical Studies and Bioactivities (2 papers), Phytochemistry and Bioactive Compounds (1 paper) and Asymmetric Synthesis and Catalysis (1 paper). The work is most often cited by research in Biotechnology (410 citations), Pharmacology (469 citations) and Toxicology (46 citations). Taro Amagata has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Phillip Crews, Katsuhiko Minoura, Atsushi Numata, Karen Tenney, Frederick A. Valeriote, Tadayoshi Ito, Emil B. Lobkovsky, Jon Clardy, Akiko Amagata and Mitsunobu Doi. Their work appears in journals such as Chemical Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.